Large Animal Facility for Imaging and Image-guided Therapies at MSU

密歇根州立大学用于成像和图像引导治疗的大型动物设施

基本信息

  • 批准号:
    10373769
  • 负责人:
  • 金额:
    $ 672.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-20 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT Precision health is an emerging paradigm in healthcare that focuses on early detection and molecular determinants of disease. Michigan State University (MSU) has launched a University-wide initiative to bring the principles of precision health into its healthcare systems. The success of this initiative depends, in large part, on our ability to obtain relevant data from predictive pre-clinical animal models and effective translational research. Advances in molecularly targeted diagnostic and therapeutic agents, the cornerstones of precision medicine, require reliable testing in informative animal models of human biology. Small laboratory animals (rodents) commonly used in biomedical research are often not suitable for studying pathologies where physiology, human markers, physical size, gestation length, lifespan, and other human-like features are key contributors to disease. Use of larger animal species for research, including dogs, pigs and sheep, can overcome many of these hurdles. It is widely accepted that in vivo imaging plays a pivotal role in nearly all areas of biomedical research and clinical practice, and the importance of its role will only increase with the development of new agents and therapies. However, imaging data obtained in small animal imaging systems cannot always be directly translated to studies in humans. Clearly, studying large animal models using clinical scanners would produce data that are closest to what we expect in humans, and would better inform translational studies. Further, the ability to study comparative diseases that occur spontaneously in domesticated species, as part of clinical studies of client- owned animals, will add further to translational relevance and data outcomes. For these reasons and to advance the clinical relevance of animal models, we are requesting funds to develop a multi-species large animal imaging facility at MSU. This facility will be equipped with a state-of-the-art high-end clinical imaging system (PET/MRI, mMR Biograph, Siemens) that would serve MSU’s diverse biomedical scientific and clinical communities. Researchers will use this facility for studies of large research animals, and client-owned companion animals to develop imaging and image-guided therapy approaches with focus on human pathologies linked to significant mortality rates (e.g., cardiovascular disease, cancer, and diabetes). This multidisciplinary facility will also support ongoing clinical trials in human subjects and serve as a training ground for undergraduate, graduate and postdoctoral trainees from 6 colleges, 12 departments and 7 programs. performing research on a full spectrum of human and animal disease models. This new biomedical imaging facility, in combination with human and veterinary expertise at MSU, creates an extraordinary opportunity to perform pre-clinical, clinical and translational research using clinical imaging equipment. These capabilities will promote high-level collaborations between MSU and investigators at regional and national institutions to ultimately champion and advance a premiere program in precision health and comparative medicine, benefiting both human and animal health in the diagnosis and treatment of disease.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANNA MOORE其他文献

ANNA MOORE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANNA MOORE', 18)}}的其他基金

Novel Prostate cancer therapy based on m-aconitase inhibition
基于 m-乌头酸酶抑制的新型前列腺癌疗法
  • 批准号:
    10435673
  • 财政年份:
    2022
  • 资助金额:
    $ 672.12万
  • 项目类别:
Novel Prostate cancer therapy based on m-aconitase inhibition
基于 m-乌头酸酶抑制的新型前列腺癌疗法
  • 批准号:
    10580844
  • 财政年份:
    2022
  • 资助金额:
    $ 672.12万
  • 项目类别:
Therapy for Metastatic breast cancer based on micro RNA silencing
基于微小RNA沉默的转移性乳腺癌治疗
  • 批准号:
    10434241
  • 财政年份:
    2021
  • 资助金额:
    $ 672.12万
  • 项目类别:
anti-miR-10b Nanodrug for Treatment of Breast Cancer Metastasis: Study in Companion Animals
用于治疗乳腺癌转移的抗 miR-10b 纳米药物:伴侣动物研究
  • 批准号:
    10659027
  • 财政年份:
    2021
  • 资助金额:
    $ 672.12万
  • 项目类别:
anti-miR-10b Nanodrug for Treatment of Breast Cancer Metastasis: Study in Companion Animals
用于治疗乳腺癌转移的抗 miR-10b 纳米药物:伴侣动物研究
  • 批准号:
    10450168
  • 财政年份:
    2021
  • 资助金额:
    $ 672.12万
  • 项目类别:
Therapy for Metastatic breast cancer based on micro RNA silencing
基于微小RNA沉默的转移性乳腺癌治疗
  • 批准号:
    10489811
  • 财政年份:
    2021
  • 资助金额:
    $ 672.12万
  • 项目类别:
anti-miR-10b Nanodrug for Treatment of Breast Cancer Metastasis: Study in Companion Animals
用于治疗乳腺癌转移的抗 miR-10b 纳米药物:伴侣动物研究
  • 批准号:
    10265643
  • 财政年份:
    2021
  • 资助金额:
    $ 672.12万
  • 项目类别:
Therapy for Metastatic breast cancer based on micro RNA silencing
基于微小RNA沉默的转移性乳腺癌治疗
  • 批准号:
    9979793
  • 财政年份:
    2018
  • 资助金额:
    $ 672.12万
  • 项目类别:
Therapy for Metastatic breast cancer based on micro RNA silencing
基于微小RNA沉默的转移性乳腺癌治疗
  • 批准号:
    9753181
  • 财政年份:
    2018
  • 资助金额:
    $ 672.12万
  • 项目类别:
siRNA Protection of Composite Islet Kidney Transplant in Baboons
狒狒复合胰岛肾移植的 siRNA 保护
  • 批准号:
    8970851
  • 财政年份:
    2015
  • 资助金额:
    $ 672.12万
  • 项目类别:

相似海外基金

Development of a Drosophila-based platform to replace and reduce animal experimentation in epilepsy research
开发基于果蝇的平台来取代和减少癫痫研究中的动物实验
  • 批准号:
    NC/V001051/1
  • 财政年份:
    2020
  • 资助金额:
    $ 672.12万
  • 项目类别:
    Research Grant
Doctoral Dissertation Research: Ethical Issues in Animal Experimentation
博士论文研究:动物实验的伦理问题
  • 批准号:
    1424484
  • 财政年份:
    2014
  • 资助金额:
    $ 672.12万
  • 项目类别:
    Standard Grant
Animal Experimentation Core
动物实验核心
  • 批准号:
    7665015
  • 财政年份:
    2008
  • 资助金额:
    $ 672.12万
  • 项目类别:
Core--Animal Experimentation
核心——动物实验
  • 批准号:
    7422298
  • 财政年份:
    2007
  • 资助金额:
    $ 672.12万
  • 项目类别:
Animal Experimentation Core
动物实验核心
  • 批准号:
    7502321
  • 财政年份:
    2007
  • 资助金额:
    $ 672.12万
  • 项目类别:
Tissue formation involving stem/progenitor cell research and animal experimentation (N01)
涉及干/祖细胞研究和动物实验的组织形成(N01)
  • 批准号:
    30245585
  • 财政年份:
    2006
  • 资助金额:
    $ 672.12万
  • 项目类别:
    Collaborative Research Centres
Core--Animal Experimentation
核心——动物实验
  • 批准号:
    7312565
  • 财政年份:
    2006
  • 资助金额:
    $ 672.12万
  • 项目类别:
Animal experimentation and cardiac phenotyping of transgenic mouse models
转基因小鼠模型的动物实验和心脏表型分析
  • 批准号:
    13327687
  • 财政年份:
    2005
  • 资助金额:
    $ 672.12万
  • 项目类别:
    Research Units
Animal Experimentation system as an infrastructure to support translational progression of diabetes research to medical practice
动物实验系统作为支持糖尿病研究向医学实践转化的基础设施
  • 批准号:
    17200029
  • 财政年份:
    2005
  • 资助金额:
    $ 672.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Core--Animal Experimentation
核心——动物实验
  • 批准号:
    6892955
  • 财政年份:
    2005
  • 资助金额:
    $ 672.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了